Clinical Trials List
Protocol Number103R104953
Not yet recruiting
2015-09-02 - 2018-09-02
Others
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 曾凱元 Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
250 participants
-
Global
250 participants
